PSMA-based therapeutics for prostate cancer
PV Stamatakos, C Fragkoulis, A Leventi… - Expert Opinion on …, 2024 - Taylor & Francis
ABSTRACT Introduction The prostate cancer (PCa) consists the most frequently diagnosed
malignancy of urogenital system in males. Traditionally, treatment of localized PCa was …
malignancy of urogenital system in males. Traditionally, treatment of localized PCa was …
Update on PSMA-based Prostate Cancer Imaging
E Mena, L Lindenberg, PL Choyke - Seminars in Nuclear Medicine, 2024 - Elsevier
The increased use of prostate-specific membrane antigen (PSMA) based PET imaging for
prostate cancer (Pca) detection has revolutionized the clinical management of Pca, with …
prostate cancer (Pca) detection has revolutionized the clinical management of Pca, with …
Using a novel PSMA-PET and PSA-based model to enhance the diagnostic accuracy for clinically significant prostate cancer and avoid unnecessary biopsy in men …
Y Li, J Li, J Yang, L Xiao, M Zhou, Y Cai… - European Journal of …, 2024 - Springer
Introduction The diagnostic evaluation of men with suspected prostate cancer (PCa) yet
inconclusive MRI (PI-RADS≤ 3) presents a common clinical challenge.[68Ga] Ga-labelled …
inconclusive MRI (PI-RADS≤ 3) presents a common clinical challenge.[68Ga] Ga-labelled …
[68Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer
J Clore, PJH Scott - Expert Review of Molecular Diagnostics, 2024 - Taylor & Francis
Introduction Theranostics targeting prostate-specific membrane antigen (PSMA) represent a
new targeted approach for prostate cancer care that combines diagnostic and therapeutic …
new targeted approach for prostate cancer care that combines diagnostic and therapeutic …
Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate …
T Büttner, F Gärtner, M Essler, R Weiten… - The …, 2024 - Wiley Online Library
Abstract Background Prostate cancer (PCa) diagnosis and staging have evolved with the
advent of 68Ga‐Prostate‐specific membrane antigen positron emission …
advent of 68Ga‐Prostate‐specific membrane antigen positron emission …
Evolving Paradigms in Prostate Cancer: The Integral Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary …
C Udovicich, AY Jia, A Loblaw, R Eapen… - International Journal of …, 2024 - Elsevier
Prostate-specific membrane antigen (PSMA) positron emission tomography or computed
tomography (PET/CT) has emerged as a superior imaging option to conventional imaging …
tomography (PET/CT) has emerged as a superior imaging option to conventional imaging …
Re: James P. Buteau, Daniel Moon, Michael T. Fahey, et al. Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating …
A Guidotti, R Lombardo… - European …, 2024 - euoncology.europeanurology.com
[6] Guo S, Zhang J, Wang Y, et al. Avoiding unnecessary biopsy: the combination of
PRIMARY score with prostate-specific antigen density for prostate biopsy decision. Prostate …
PRIMARY score with prostate-specific antigen density for prostate biopsy decision. Prostate …
Beyond Prostate Imaging Reporting and Data System: combining magnetic resonance imaging Prostate Imaging Reporting and Data System and prostate-specific …
Purpose: The Prostate Imaging Reporting and Data System (PI-RADS) score is standard of
care for clinically significant prostate cancer (csPCa) diagnosis. The PRIMARY score …
care for clinically significant prostate cancer (csPCa) diagnosis. The PRIMARY score …
Beyond PI-RADS: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen–Positron …
Purpose: The Prostate Imaging Reporting and Data System (PI-RADS) score is standard of
care for clinically significant prostate cancer (csPCa) diagnosis. The PRIMARY score …
care for clinically significant prostate cancer (csPCa) diagnosis. The PRIMARY score …
Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making
C Udovicich, AY Jia, A Loblaw, R Eapen… - International Journal of … - redjournal.org
Abstract PSMA PET/CT has emerged as a superior imaging option to conventional imaging
for prostate cancer. The majority of early evidence and prospective trials evaluated PSMA …
for prostate cancer. The majority of early evidence and prospective trials evaluated PSMA …